{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:05:20Z","timestamp":1789607120482,"version":"build-2803163510"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Hangzhou Special Science and Technology Program for Supporting the Development of Biomedicine and Health Industry","award":["2023WJC191"],"award-info":[{"award-number":["2023WJC191"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>We sought to evaluate the diagnostic performance of and interassay agreement between a chemiluminescence immunoassay for antimitochondrial antibody subtype M2 (AMA-M2) in patients with primary biliary cholangitis and clinically relevant disease controls with other liver diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective study, 164 patients with primary biliary cholangitis and 403 patients with other liver diseases were enrolled between December 2020 and January 2023. The AMAs were detected using indirect immunofluorescence, line immunoassay (LIA), and chemiluminescence immunoassay. Diagnostic performance was evaluated by sensitivity, specificity, accuracy, and receiver operating characteristic curve analysis. Agreement between methods was assessed using the Cohen \u03ba coefficient and correlation analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>AMA-M2 detected by chemiluminescence immunoassay had a sensitivity of 84.1%, a specificity of 90.1%, and an accuracy of 88.4%. Our receiver operating characteristic curve analysis showed an area under the curve of 0.927 (95% CI, 0.903-0.951) for AMA-M2 by chemiluminescence immunoassay, which was higher than the area under the curves for AMA-M2 by LIA (0.772) and M2-3E by LIA (0.862) (both P\u2009&amp;lt;\u2009.001). High concordance was observed between AMA-M2 by chemiluminescence immunoassay and M2-3E by LIA (96.1%, \u03ba\u2009=\u20090.908), with a strong correlation between the 2 assays.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Chemiluminescence immunoassay\u2013based detection of AMA-M2 showed high diagnostic performance and strong agreement with conventional assays in this cohort, supporting its utility as a reliable quantitative method for clinical diagnosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/labmed\/lmag063","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T11:34:30Z","timestamp":1787052870000},"source":"Crossref","is-referenced-by-count":0,"title":["Assessment of a chemiluminescence immunoassay for antimitochondrial antibody subtype M2 in the diagnosis of primary biliary cholangitis"],"prefix":"10.1093","volume":"57","author":[{"given":"Yujiao","family":"Jin","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Hangzhou Xixi Hospital , Hangzhou,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Hangzhou Xixi Hospital , Hangzhou,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aifang","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Hangzhou Xixi Hospital , Hangzhou,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaochan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Hangzhou Xixi Hospital , Hangzhou,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8349-3214","authenticated-orcid":false,"given":"Kenv","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Hangzhou Xixi Hospital , Hangzhou,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"2026091620514694200_lmag063-B1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary biliary cholangitis: 2018 practice guidance from the American Association for the Study of Liver Diseases","volume":"69","author":"Lindor","year":"2019","journal-title":"Hepatology"},{"key":"2026091620514694200_lmag063-B2","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.3748\/wjg.v29.i12.1795","article-title":"Role of autoantibodies in the clinical management of primary biliary cholangitis","volume":"29","author":"Rigopoulou","year":"2023","journal-title":"World J Gastroenterol"},{"key":"2026091620514694200_lmag063-B3","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.4049\/jimmunol.138.10.3525","article-title":"Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis","volume":"138","author":"Gershwin","year":"1987","journal-title":"J Immunol"},{"key":"2026091620514694200_lmag063-B4","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1515\/cclm-2013-0926","article-title":"The accuracy of the anti-mitochondrial antibody and the M2 subtype test for diagnosis of primary biliary cirrhosis: a meta-analysis","volume":"52","author":"Hu","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"2026091620514694200_lmag063-B5","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1080\/00365513.2025.2598748","article-title":"Quantitative detection of anti-centromere antibodies in primary biliary cholangitis: value of chemiluminescence immunoassay","volume":"85","author":"Jin","year":"2025","journal-title":"Scand J Clin Lab Invest"},{"key":"2026091620514694200_lmag063-B6","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1515\/cclm-2023-0742","article-title":"Diagnostic and prognostic value of quantitative detection of antimitochondrial antibodies subtype M2 using chemiluminescence immunoassay in primary biliary cholangitis","volume":"62","author":"Wang","year":"2024","journal-title":"Clin Chem Lab Med"},{"key":"2026091620514694200_lmag063-B7","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/S0140-6736(65)91372-3","article-title":"Serological tests in diagnosis of primary biliary cirrhosis","volume":"1","author":"Walker","year":"1965","journal-title":"Lancet"},{"key":"2026091620514694200_lmag063-B8","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.3748\/wjg.14.3374","article-title":"Autoimmune liver serology: current diagnostic and clinical challenges","volume":"14","author":"Bogdanos","year":"2008","journal-title":"World J Gastroenterol"},{"key":"2026091620514694200_lmag063-B9","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jaut.2018.10.004","article-title":"The clinical usage and definition of autoantibodies in immune-mediated liver disease: a comprehensive overview","volume":"95","author":"Terziroli Beretta-Piccoli","year":"2018","journal-title":"J Autoimmun"},{"key":"2026091620514694200_lmag063-B10","doi-asserted-by":"publisher","first-page":"e47702","DOI":"10.7759\/cureus.47702","article-title":"The role of indirect immunofluorescence (IIF) and line immunoassay (LIA) in the diagnosis of autoimmune diseases and their clinical correlation: an observational study from a tertiary care center in Bihar","volume":"15","author":"Kumar","year":"2023","journal-title":"Cureus"},{"key":"2026091620514694200_lmag063-B11","doi-asserted-by":"publisher","first-page":"343182","DOI":"10.1016\/j.aca.2024.343182","article-title":"Glow-type luminol chemiluminescence based on a supramolecular enhancer of cyclodextrin","volume":"1328","author":"Hu","year":"2024","journal-title":"Anal Chim Acta"},{"key":"2026091620514694200_lmag063-B12","doi-asserted-by":"publisher","first-page":"12793","DOI":"10.1021\/acs.analchem.1c03242","article-title":"Development of a fast chemiluminescent magneto-immunoassay for sensitive Plasmodium falciparum detection in whole blood","volume":"93","author":"Sanchez-Cano","year":"2021","journal-title":"Anal Chem"},{"key":"2026091620514694200_lmag063-B13","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.55730\/1300-0144.5512","article-title":"Performance of indirect immunofluorescence test and immunoblot tests in the evaluation of antinuclear and antimitochondrial antibodies","volume":"52","author":"Ozturk","year":"2022","journal-title":"Turk J Med Sci"},{"key":"2026091620514694200_lmag063-B14","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/gnag214s10875-007-9092-0","article-title":"Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis","volume":"27","author":"Gabeta","year":"2007","journal-title":"J Clin Immunol"},{"key":"2026091620514694200_lmag063-B15","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/hep.21583","article-title":"A sensitive bead assay for antimitochondrial antibodies: chipping away at AMA-negative primary biliary cirrhosis","volume":"45","author":"Oertelt","year":"2007","journal-title":"Hepatology"},{"key":"2026091620514694200_lmag063-B16","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/hep.510270303","article-title":"Characterization of antimitochondrial antibodies in healthy adults","volume":"27","author":"Mattalia","year":"1998","journal-title":"Hepatology"},{"key":"2026091620514694200_lmag063-B17","first-page":"124","article-title":"A study of antimitochondrial antibodies in a random population in Estonia","volume":"92","author":"Turchany","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"2026091620514694200_lmag063-B18","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/S0140-6736(96)04410-8","article-title":"Natural history of early primary biliary cirrhosis","volume":"348","author":"Metcalf","year":"1996","journal-title":"Lancet"},{"key":"2026091620514694200_lmag063-B19","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/joim.13005","article-title":"Low rate of new-onset primary biliary cholangitis in a cohort of anti-mitochondrial antibody-positive subjects over six years of follow-up","volume":"287","author":"Zandanell","year":"2020","journal-title":"J Intern Med"},{"key":"2026091620514694200_lmag063-B20","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/hep.28859","article-title":"Large-scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis","volume":"65","author":"Dahlqvist","year":"2017","journal-title":"Hepatology"},{"key":"2026091620514694200_lmag063-B21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jaut.2019.01.005","article-title":"Histologically proven AMA positive primary biliary cholangitis but normal serum alkaline phosphatase: is alkaline phosphatase truly a surrogate marker?","volume":"99","author":"Sun","year":"2019","journal-title":"J Autoimmun"},{"key":"2026091620514694200_lmag063-B22","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s005350170111","article-title":"The follow-up of asymptomatic persons with antibodies to pyruvate dehydrogenase in adult population samples","volume":"36","author":"Kisand","year":"2001","journal-title":"J Gastroenterol"},{"key":"2026091620514694200_lmag063-B23","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1111\/apt.70614","article-title":"Dual positivity for AMA\/AMA-M2 and anti-gp210\/sp100 shows highest diagnostic value for primary biliary cholangitis","volume":"63","author":"Liu","year":"2026","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/labmed\/article-pdf\/57\/5\/lmag063\/71131484\/lmag063.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/labmed\/article-pdf\/57\/5\/lmag063\/71131484\/lmag063.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:52:23Z","timestamp":1789606343000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/labmed\/article\/doi\/10.1093\/labmed\/lmag063\/8802618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,8,4]]}},"URL":"https:\/\/doi.org\/10.1093\/labmed\/lmag063","relation":{},"ISSN":["0007-5027","1943-7730"],"issn-type":[{"value":"0007-5027","type":"print"},{"value":"1943-7730","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,8,4]]},"article-number":"lmag063"}}